Baseline characteristics of control subjects and diabetic patients
| . | Control subjects . | Diabetic patients . |
|---|---|---|
| n | 14 | 12 |
| Age (years) | 53 ± 6 | 57 ± 6 |
| Men (n) | 12 | 8 |
| BMI (kg/m2) | 25.6 ± 2.0 | 29.0 ± 5.0 |
| Heart rate (beats/min) | 63 ± 11 | 89 ± 12 |
| Systolic blood pressure (mmHg) | 136 ± 12 | 141 ± 20 |
| Diastolic blood pressure (mmHg) | 86 ± 7 | 89 ± 12 |
| Total cholesterol (mmol/l) | 5.5 ± 0.8 | 4.3 ± 1.4 |
| HDL cholesterol (mmol/l) | 1.8 ± 0.4 | 1.3 ± 0.4 |
| LDL cholesterol (mmol/l) | 3.2 ± 0.8 | 2.6 ± 0.9 |
| Triglycerides (mmol/l) | 1.1 ± 0.3 | 1.7 ± 1.4 |
| A1C (%) | 5.5 ± 0.4 | 7.0 ± 1.5 |
| Fasting plasma insulin (pmol/l) | 42.5 ± 29.7 | 62.8 ± 30.3 |
| Fasting plasma glucose (mmol/l) | 5.3 ± 0.4 | 8.0 ± 2.7 |
| M value (mg glucose · g−1 · min−1) | 10.2 ± 4.6 | 6.0 ± 3.8 |
| . | Control subjects . | Diabetic patients . |
|---|---|---|
| n | 14 | 12 |
| Age (years) | 53 ± 6 | 57 ± 6 |
| Men (n) | 12 | 8 |
| BMI (kg/m2) | 25.6 ± 2.0 | 29.0 ± 5.0 |
| Heart rate (beats/min) | 63 ± 11 | 89 ± 12 |
| Systolic blood pressure (mmHg) | 136 ± 12 | 141 ± 20 |
| Diastolic blood pressure (mmHg) | 86 ± 7 | 89 ± 12 |
| Total cholesterol (mmol/l) | 5.5 ± 0.8 | 4.3 ± 1.4 |
| HDL cholesterol (mmol/l) | 1.8 ± 0.4 | 1.3 ± 0.4 |
| LDL cholesterol (mmol/l) | 3.2 ± 0.8 | 2.6 ± 0.9 |
| Triglycerides (mmol/l) | 1.1 ± 0.3 | 1.7 ± 1.4 |
| A1C (%) | 5.5 ± 0.4 | 7.0 ± 1.5 |
| Fasting plasma insulin (pmol/l) | 42.5 ± 29.7 | 62.8 ± 30.3 |
| Fasting plasma glucose (mmol/l) | 5.3 ± 0.4 | 8.0 ± 2.7 |
| M value (mg glucose · g−1 · min−1) | 10.2 ± 4.6 | 6.0 ± 3.8 |
Data are means ± SD.